898 studies found for:    Open Studies | "Insulin"
Show Display Options
Rank Status Study
21 Recruiting TReatment by Insulin Continuous Infusion in Type 2 DIAbetes
Condition: Diabetes
Intervention: Drug: 2 different procedures of administration of insulin
22 Recruiting Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in Pregnancy
Conditions: Diabetes, Gestational;   Diabetes, Type 2
Intervention: Drug: Insulin
23 Recruiting Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting
Condition: Type 1 Diabetes
Interventions: Device: Closed loop with enlite sensors, insulin, liraglutide;   Device: Closed loop with enlite sensors, insulin
24 Recruiting Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Pilot Study)
Condition: Type 2 Diabetes
Interventions: Drug: Intermittent insulin therapy;   Drug: Continuous metformin
25 Unknown  Effect of Intensive Insulin Therapy on Clinical Prognosis of Infants Undergoing Cardiac Surgery
Condition: Cardiac Surgery
Interventions: Other: Intensive insulin therapy;   Other: Conventional insulin therapy
26 Recruiting Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Main Trial)
Condition: Type 2 Diabetes
Interventions: Drug: Metformin alone;   Drug: Metformin + Intermittent Insulin Therapy
27 Not yet recruiting Comparison of Insulin Pump and MDI for Pregestational Diabetes During Pregnancy
Conditions: Type 1 Diabetes;   Type 2 Diabetes;   Pregnancy
Interventions: Device: Animas;   Other: multiple daily insulin injection
28 Recruiting The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized Patients
Conditions: Hyperglycemia;   Diabetes Mellitus
Interventions: Drug: Active Comparator: Glargine/Lispro insulin;   Drug: Glargine/Lispro/NPH insulin arm
29 Not yet recruiting Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia
Conditions: Type 1 Diabetes Mellitus;   Nocturnal Hypoglycemia;   Recurrent Severe Hypoglycaemia
Interventions: Drug: Insulin aspart/glargine;   Drug: Insulin aspart/degludec
30 Recruiting Closed Loop Insulin Pump Therapy After Islet Auto-Transplantation
Conditions: Chronic Pancreatitis;   Diabetes Mellitus
Intervention: Device: Closed Loop Insulin
31 Recruiting Metabolic Signalling in Muscle- and Adipose-tissue Following Insulin Withdrawal and Growth Hormone Injection.
Conditions: Diabetes Mellitus Type I;   Ketoacidosis
Interventions: Drug: Insulin withdrawal;   Drug: Norditropin
32 Recruiting A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Interventions: Drug: insulin degludec;   Drug: insulin glargine
33 Recruiting Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Insulin glargine/lixisenatide HOE901/AVE0010;   Drug: Insulin glargine HOE901;   Drug: Metformin
34 Not yet recruiting Closed-loop Insulin Delivery in the General Ward
Condition: Diabetes Mellitus
Interventions: Device: Fully Automated Closed-Loop Insulin Delivery;   Device: Conventional insulin therapy
35 Recruiting Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM
Condition: Type 2 Diabetes
Interventions: Drug: Insulin glargine/lixisenatide HOE901/AVE0010;   Drug: Insulin glargine HOE901;   Drug: Lixisenatide AVE0010;   Drug: Metformin
36 Recruiting A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-response and Dose-exposure Relationship of BioChaperone Insulin Lispro in Three Different Doses in Subjects With Type 1 Diabetes
Condition: Diabetes Mellitus Type 1
Interventions: Drug: BioChaperone insulin lispro 0.2U/Kg;   Drug: BioChaperone insulin lispro 0.1U/Kg;   Drug: BioChaperone insulin lispro 0.4U/Kg;   Drug: Humalog®
37 Recruiting Effect of CSII and CGM on Progression of Late Diabetic Complications
Condition: Type 1 Diabetes Mellitus
Interventions: Device: Insulin pump therapy (CSII) plus continuous glucose monitoring (CGM);   Other: Multiple daily insulin injections (MDI)
38 Recruiting Glucose Control for Glucocorticoid Induced Hyperglycemia During Chemotherapy
Condition: Hyperglycemia Steroid-induced
Interventions: Drug: Sliding scale insulin;   Drug: Intermediate acting insulin;   Behavioral: Dietary advice;   Drug: Glucose lowering medication;   Drug: Chemotherapy
39 Recruiting Heart And Lung Failure - Pediatric INsulin Titration Trial
Conditions: Heart Failure;   Respiratory Failure
Intervention: Drug: Insulin
40 Not yet recruiting PK/PD STUDY OF U-500 REGULAR INSULIN
Conditions: Type 2 Diabetes;   Insulin Resistance;   High Insulin Requirements
Intervention: Drug: U-500 insulin

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years